BMED stock forecast, quote, news & analysis

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Unitedhealth Group (NYSE:UNH), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), Abbott Laboratories (NYSE:ABT), Amgen (NASDAQ:AMGN), Intuitive Surgical (NASDAQ:ISRG), Elevance Health (NYSE:ELV), Boston Scientific Corp (NYSE:BSX), McKesson Corp (NYSE:MCK).

The investment seeks to maximize total return. Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries. While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants.

The average market capitalization across the iShares Health Innovation Active ETF ETF is 33.19B. The market cap for tickers in the group ranges from 141.34M to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is SGMT at 141.34M.

The average weekly price growth across all stocks in the iShares Health Innovation Active ETF ETF was 19%. For the same ETF, the average monthly price growth was 87%, and the average quarterly price growth was 97%. NVCR experienced the highest price growth at 19%, while KROS experienced the biggest fall at -73%.

The average weekly volume growth across all stocks in the iShares Health Innovation Active ETF ETF was 10%. For the same stocks of the ETF, the average monthly volume growth was -9% and the average quarterly volume growth was 25%